| Historic (2004-11-01 to
2009-06-04) |
| Rank |
Entity Name |
Count |
Score |
Coref./Ref. |
| 1 |
PSA
|
3400 |
49439.3 |
  |
| 2 |
prostate cancer
|
3515 |
46470.4 |
  |
| 3 |
prostate-specific antigen
|
2060 |
30804.6 |
  |
| 4 |
prostate specific antigen
|
1712 |
28001.6 |
  |
| 5 |
protein
|
1624 |
22379.0 |
  |
| 6 |
cancer
|
1355 |
18706.2 |
  |
| 7 |
flu
|
1110 |
15704.7 |
  |
| 8 |
H5N1
|
810 |
13100.0 |
  |
| 9 |
digital rectal exam
|
790 |
12666.4 |
  |
| 10 |
HCV
|
660 |
11728.6 |
  |
| 11 |
hepatitis
|
770 |
11536.1 |
  |
| 12 |
U.S.
|
890 |
10740.3 |
  |
| 13 |
CEA
|
450 |
7177.1 |
  |
| 14 |
NY-ESO-1
|
370 |
6755.8 |
  |
| 15 |
CD4+
|
370 |
6499.3 |
  |
|
| 365 days (2008-06-04 to
2009-06-04) |
| Rank |
Entity Name |
Count |
Score |
Coref./Ref. |
| 1 |
PSA
|
1300 |
18057.9 |
  |
| 2 |
prostate cancer
|
1025 |
13505.0 |
  |
| 3 |
prostate-specific antigen
|
720 |
10657.8 |
  |
| 4 |
protein
|
554 |
6995.6 |
  |
| 5 |
digital rectal exam
|
400 |
6310.5 |
  |
| 6 |
NY-ESO-1
|
370 |
6281.0 |
  |
| 7 |
CD4+
|
370 |
6024.5 |
  |
| 8 |
prostate specific antigen
|
342 |
5520.1 |
  |
| 9 |
U.S.
|
430 |
4940.3 |
  |
| 10 |
CEA
|
240 |
3564.9 |
  |
| 11 |
CTC
|
190 |
2907.9 |
  |
| 12 |
circulating tumor cells
|
190 |
2907.9 |
  |
| 13 |
U.S. Preventive Services Task Force
|
160 |
2734.5 |
  |
| 14 |
B27
|
160 |
2635.9 |
  |
| 15 |
prostate-screening antigen
|
160 |
2594.4 |
  |
|
| 30 days (2009-05-05 to
2009-06-04) |
| Rank |
Entity Name |
Count |
Score |
Coref./Ref. |
| 1 |
PSA
|
180 |
2168.2 |
  |
| 2 |
The American Urological Association
|
70 |
989.6 |
  |
| 3 |
10 years
|
70 |
849.3 |
  |
| 4 |
prostate cancer
|
50 |
660.4 |
  |
| 5 |
cancer
|
50 |
658.2 |
  |
| 6 |
prostate specific antigen
|
40 |
575.6 |
  |
| 7 |
flu
|
40 |
508.8 |
  |
| 8 |
US180
|
30 |
481.4 |
  |
| 9 |
US
|
30 |
423.0 |
  |
| 10 |
CA-125
|
20 |
372.7 |
  |
| 11 |
ovarian cancer
|
20 |
372.7 |
  |
| 12 |
2 years
|
20 |
338.7 |
  |
| 13 |
3 years
|
20 |
328.8 |
  |
| 14 |
HHS
|
20 |
326.7 |
  |
| 15 |
HLA
|
20 |
311.6 |
  |
|